Comparative Efficacy of Oral Extended-Release Hydromorphone and Immediate-Release Hydromorphone in Patients with Persistent Moderate to Severe Pain: Two Randomized Controlled Trials
Open Access
- 30 June 2005
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 29 (6) , 584-594
- https://doi.org/10.1016/j.jpainsymman.2004.10.008
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer painCancer, 1997
- Pharmacologic Treatment of Cancer PainNew England Journal of Medicine, 1996
- Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer painCancer, 1994
- Individual variability in the response to different opioids: report of five casesPain, 1992
- The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusionsPain, 1990
- Hydromorphone levels and pain control in patients with severe chronic painClinical Pharmacology & Therapeutics, 1988
- The Treatment of Cancer PainNew England Journal of Medicine, 1985
- Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseasesPAIN®, 1983
- Sources of variation in analgesic responses in cancer patients with chronic pain receiving morphinePain, 1983
- Clinical pharmacology of analgesics: 1. A method of assaying analgesic effectClinical Pharmacology & Therapeutics, 1960